Nanobiotix (NBTX) Total Current Liabilities (2018 - 2025)
Nanobiotix (NBTX) posted Total Current Liabilities of $66.9 million for Q4 2025, up 6.29% on a QoQ basis from $63.0 million in Q4 2024, and up 6.29% year-over-year from $63.0 million in Q4 2024.
Nanobiotix (NBTX) has 8 years of Total Current Liabilities data on file, last reported at $66.9 million in Q4 2025.
- In Q4 2025, Total Current Liabilities rose 6.29% year-over-year to $66.9 million; the TTM figure through Dec 2025 stood at $66.9 million (up 6.29% YoY), while the FY2025 annual figure was $65.0 million, up 1.86% from the prior year.
- Total Current Liabilities grew to $66.9 million in Q4 2025, from $63.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $66.9 million in Q4 2025 and bottomed at $38.7 million in Q4 2022.
- A 5-year average of $52.9 million and a median of $53.7 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities surged 85.66% — and 2022, when it fell 8.17%.
- Year by year, Total Current Liabilities stood at $42.1 million in 2021, then declined by 8.17% to $38.7 million in 2022, then jumped by 38.64% to $53.7 million in 2023, then climbed by 17.36% to $63.0 million in 2024, then rose by 6.29% to $66.9 million in 2025.
- The last three Total Current Liabilities figures came in at $66.9 million (Q4 2025), $63.0 million (Q4 2024), and $53.7 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 289.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.94 Mn |
| Jun 30, 2025 | 71.36 Mn |
| Dec 31, 2024 | 62.98 Mn |
| Jun 30, 2024 | 60.86 Mn |
| Dec 31, 2023 | 53.66 Mn |
| Jun 30, 2023 | 54.29 Mn |
| Dec 31, 2022 | 38.70 Mn |
| Jun 30, 2022 | 45.44 Mn |
| Dec 31, 2021 | 42.15 Mn |
| Jun 30, 2021 | 45.81 Mn |
| Dec 31, 2020 | 22.70 Mn |
| Dec 31, 2019 | 15.88 Mn |
| Dec 31, 2018 | 13.24 Mn |